Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bimatoprost (lashes) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Prescription topical. Bimatoprost 0.03% is applied once daily as a thin line to the skin of the UPPER eyelid margin at the lash base (not to the lower lid, and avoid getting it in the eye), using a fresh applicator per eye. Continuous use is needed to maintain results. Use under a clinician, especially if you have glaucoma or take prostaglandin eye drops. There is no oral or systemic use. This library does not provide an ingestion protocol.
evening
Bimatoprost 0.03% solution (Latisse) with single-use applicators, under a clinician
Topical cosmetic only. Acne trials used a 5% tea tree oil gel applied to affected areas (typically twice daily). Avoid undiluted (100%) application, which is more irritating and sensitizing. Patch-test first, and use fresh, properly stored product (oxidized oil raises allergy risk). There is no oral or systemic dose — it is not ingested (and tea tree oil is toxic if swallowed). This library does not provide an ingestion protocol.
any
5% tea tree oil gel (the trial-tested strength)
Throughout
8-16 weeks
2-6 months after stopping
Weeks to months
Throughout
8-12 weeks
Weeks
Throughout
Long-term safety and efficacy of bimatoprost solution 0.03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
Br J Dermatol (2015) · Rct
1-year double-masked RCT: composite primary endpoint (Global Eyelash Assessment + satisfaction) met for bimatoprost vs vehicle in idiopathic (40.2% vs 6.8%) and post-chemotherapy (37.5% vs 18.2%) hypotrichosis
Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
Aesthetic Plast Surg (2014) · Rct · n=209
Two double-masked vehicle-controlled RCTs (n=209: 173 idiopathic, 36 chemotherapy-induced) in Japanese subjects
The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis.
Front Med (Lausanne) (2023) · Meta analysis
Meta-analysis of six placebo-controlled RCTs of topical prostaglandin analogs (incl. bimatoprost) for hair growth (lashes, brows, scalp)
A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne.
Med J Aust (1990) · Rct · n=124
Single-blind RCT in 124 patients comparing 5% tea tree oil gel with 5% benzoyl peroxide lotion for mild-to-moderate acne
The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study.
Indian J Dermatol Venereol Leprol (2007) · Rct · n=60
Randomized double-blind placebo-controlled trial (n=60) of 5% tea tree oil gel vs placebo over 45 days
Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study.
Australas J Dermatol (2017) · Pilot · n=18
Open-label, uncontrolled 12-week phase II pilot of a tea tree oil gel and face wash applied twice daily (n=18)
Bimatoprost (lashes) has a higher evidence score (8/10 vs 5/10) and wins in 2 of 3 categories.
No known interactions between Bimatoprost (lashes) and Tea Tree Oil (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.